Nasdaq Stockholm

Medivir to present at Swiss Nordic Bio in Zürich on March 7

Retrieved on: 
Wednesday, March 6, 2024
Market capitalization, Nasdaq Stockholm, Acceleration, Drug development, Trial of the century, Liver cancer, Patient, Cancer, Partnership, Pharmaceutical industry

CEO Jens Lindberg will present Medivir with focus on data from the ongoing phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox) and how these data enable an acceleration of fostrox's development program.

Key Points: 
  • CEO Jens Lindberg will present Medivir with focus on data from the ongoing phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox) and how these data enable an acceleration of fostrox's development program.
  • Swiss Nordic Bio aims to bring together biotech, pharma and life science investors from Switzerland and the Nordic region.
  • In addition to the presentation, the company will also conduct a number of 1-1 meetings with potential investors and partners.
  • Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership.

Repurchases of shares by Concentric AB during week 9, 2024

Retrieved on: 
Tuesday, March 5, 2024
Nasdaq Stockholm, Person

All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of Concentric.

Key Points: 
  • All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of Concentric.
  • Following the above acquisitions, Concentric's holding of own shares amounts to 1,104,020 shares as of 1 March 2024.
  • The total number of shares in Concentric, including the own shares, is 38,297,600 and the number of outstanding shares, excluding the own shares, is 37,193,580.
  • The information was submitted for publication, through the agency of the contact persons set out above, at 08:00 CET on 5th March 2024.

Medivir to present at the Life Science Day in Gothenburg on March 6

Retrieved on: 
Monday, March 4, 2024
Nasdaq Stockholm, Drug development, Liver cancer, Conference, Patient, Acceleration, Market capitalization, Sahlgrenska University Hospital, Cancer, Partnership, Pharmaceutical industry

CEO Jens Lindberg will present Medivir with focus on data from the ongoing Phase 1b/2a clinical trial with fostroxacitabine bralpamide (fostrox) and how these data enable an acceleration of fostrox's development program.

Key Points: 
  • CEO Jens Lindberg will present Medivir with focus on data from the ongoing Phase 1b/2a clinical trial with fostroxacitabine bralpamide (fostrox) and how these data enable an acceleration of fostrox's development program.
  • The Life Science Day in Gothenburg is arranged for the eighth time.
  • Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a pro-drug designed to selectively treat liver cancer and to minimize side effects.
  • Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership.

Notice of Ericsson's Annual General Meeting 2024

Retrieved on: 
Wednesday, February 28, 2024
Transfer, Person, Travel, Greenhouse, Nasdaq Stockholm, Annual report, F5, Inc., Cisco, Peer group, Corporation, Bank statement, Equity swap, IBM, Ethics, Participation, Compensation, Section 31, Swedish, Social Security, Treasury, Companies Act, Remuneration, Guideline, Chapter Four, Executive, Woman, Committee, Motorola Solutions, Calendar, ESG, LTV, Carbon, Business travel, Employment, Carbon accounting, GHG, Acquisition, KC, Air travel, Note, TSR, CGI Inc., Investor AB, AGM, Annual, Security (finance)

Information about the outcome of the performance criteria will be provided no later than in the annual report for the financial year 2026.

Key Points: 
  • Information about the outcome of the performance criteria will be provided no later than in the annual report for the financial year 2026.
  • The new shares shall be subscribed for during the period as from April 25, 2024, up to and including May 2, 2024.
  • The Company has decided to implement one other share-related compensation program for 2024: the Key Contribution Plan 2024 ("KC Plan 2024").
  • The new shares shall be subscribed for during the period as from April 25, 2024, up to and including May 2, 2024.

Notice of Ericsson's Annual General Meeting 2024

Retrieved on: 
Wednesday, February 28, 2024
Transfer, Person, Travel, Greenhouse, Nasdaq Stockholm, Annual report, F5, Inc., Cisco, Peer group, Corporation, Bank statement, Equity swap, IBM, Ethics, Participation, Compensation, Section 31, Swedish, Social Security, Treasury, Companies Act, Remuneration, Guideline, Chapter Four, Executive, Woman, Committee, Motorola Solutions, Calendar, ESG, LTV, Carbon, Business travel, Employment, Carbon accounting, GHG, Acquisition, KC, Air travel, Note, TSR, CGI Inc., Investor AB, AGM, Annual, Security (finance)

Information about the outcome of the performance criteria will be provided no later than in the annual report for the financial year 2026.

Key Points: 
  • Information about the outcome of the performance criteria will be provided no later than in the annual report for the financial year 2026.
  • The new shares shall be subscribed for during the period as from April 25, 2024, up to and including May 2, 2024.
  • The Company has decided to implement one other share-related compensation program for 2024: the Key Contribution Plan 2024 ("KC Plan 2024").
  • The new shares shall be subscribed for during the period as from April 25, 2024, up to and including May 2, 2024.

Annual General Meeting of AB Volvo

Retrieved on: 
Wednesday, February 21, 2024
AB, Annual general meeting, Volvo, Election Committee (Hong Kong), Chapter Eight, AFA, The Annual Report, BankID, Post office box, Consolidation, Annual report, Audit, Telephone, Meeting, Address, Nasdaq Stockholm, AMF, Coffee, Audit committee, Proxy, Companies Act, EUR, Headquarters, Report, AGM, Privacy, Mass meeting, Annual, Auditor, Security (finance)

GOTHENBURG, Sweden, Feb. 21, 2024 /PRNewswire/ -- AB Volvo (publ) ("Volvo") gives notice to attend the Annual General Meeting at Konserthuset, Götaplatsen, Göteborg, Wednesday, March 27, 2024, at 3.00 p.m.

Key Points: 
  • GOTHENBURG, Sweden, Feb. 21, 2024 /PRNewswire/ -- AB Volvo (publ) ("Volvo") gives notice to attend the Annual General Meeting at Konserthuset, Götaplatsen, Göteborg, Wednesday, March 27, 2024, at 3.00 p.m.
    Volvo warmly welcomes its shareholders to the Annual General Meeting.
  • The main entrance of Konserthuset opens for registration at 2.00 p.m. and the Annual General Meeting begins at 3.00 p.m. Coffee and cakes will be served in connection with the Annual General Meeting.
  • AB Volvo (publ) ("Volvo") gives notice to attend the Annual General Meeting at Konserthuset, Götaplatsen, Göteborg, Wednesday, March 27, 2024, at 3.00 p.m.
    Volvo warmly welcomes its shareholders to the Annual General Meeting.
  • The main entrance of Konserthuset opens for registration at 2.00 p.m. and the Annual General Meeting begins at 3.00 p.m. Coffee and cakes will be served in connection with the Annual General Meeting.

Proposal for Board of Directors of AB Volvo

Retrieved on: 
Tuesday, February 20, 2024
AB, Volvo, Election Committee (Hong Kong), AFA, Nasdaq Stockholm, AMF, EUR, Annual, Automotive industry

As previously announced, the Election Committee of AB Volvo proposes Pär Boman to be elected new Chairman of the Board and Board member at the Annual General Meeting on March 27, 2024.

Key Points: 
  • As previously announced, the Election Committee of AB Volvo proposes Pär Boman to be elected new Chairman of the Board and Board member at the Annual General Meeting on March 27, 2024.
  • AB Volvo's current Chairman of the Board Carl-Henric Svanberg will not stand for re-election.
  • The Election Committee of AB Volvo comprises representatives of four of the company's largest shareholders, who together represent approximately 15.9 percent of the shares and approximately 39.6 percent of the votes, and the Chairman of the Board.
  • The Volvo Group is headquartered in Gothenburg, Sweden, employs more than 100,000 people and serves customers in almost 190 markets.

Repurchases of shares by Concentric AB during week 7, 2024

Retrieved on: 
Tuesday, February 20, 2024
Nasdaq Stockholm, Person

All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of Concentric.

Key Points: 
  • All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of Concentric.
  • Following the above acquisitions, Concentric's holding of own shares amounts to 1,056,353 shares as of 16 February 2024.
  • The total number of shares in Concentric, including the own shares, is 38,297,600 and the number of outstanding shares, excluding the own shares, is 37,241,247.
  • The information was submitted for publication, through the agency of the contact persons set out above, at 08:00 CET on 20th February 2024.

Millicom (Tigo) share repurchase activity

Retrieved on: 
Friday, February 16, 2024
MAR, Nasdaq Stockholm, Harbor, Treasury

All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.

Key Points: 
  • All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.
  • Following the purchases, Millicom holds 1,595,370 treasury shares as of February 16, 2024.
  • The repurchase program is being executed consistent with the provisions of Article 5 of MAR and the Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”).
  • For information about all transactions carried out under the repurchase program, refer to Nasdaq Stockholm’s website: http://www.nasdaqomx.com/transactions/markets/nordic/corporate-actions/s...

EQS-News: LR Global Holding GmbH achieves sales and earnings growth in 2023 and aims to refinance its 2021/2025 bond ahead of time

Retrieved on: 
Tuesday, February 13, 2024
Interface (computing), Bond, Nasdaq Stockholm, Growth, Aloe vera, ARCTIC, Health, EUR, Frankfurt Stock Exchange, Partnership, Security (finance)

Normalized FY 2023 EBITDA amounted to EUR 35.5 million (2022: EUR 36.3 million).

Key Points: 
  • Normalized FY 2023 EBITDA amounted to EUR 35.5 million (2022: EUR 36.3 million).
  • We are therefore seeking to refinance the Existing Bond by issuing a New Bond in the “Nordic Bond” format.
  • The LR Group aims to list the New Bond on the Open Market of the Frankfurt Stock Exchange.
  • The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.